Microbiocidal N-phenyl-N-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives

ABSTRACT

The invention relates to novel N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives of the general formula (I) wherein the sum of (m+p) together is 0, 1, 2 or 3; n and q are independently of each other 0 or 1, and the sum of (m+p+q) together is 1, 2, 3 or 4; R 1  is hydrogen, halogen, alkoxy, haloalkyl, haloalkoxy or alkyl; R 2  is hydrogen, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl or C 1 –C 6 -alkoxy; R 2A  is hydrogen, C 1 –C 6 -alkyl, C 3 –C 4 -alkenyl or C 3 –C 4 -alkynyl; each of R 3 , R 4 , R 5  and R 6  is, independently of the others, hydrogen, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, hydroxy-C 1 –C 6 -alkyl or C 1 –C 6 -alkoxy-C 1 –C 6 -alkyl, or the ring members CR 3 R 4  or CR 5 R 6  or CR 2 R 2A  are independently of each other a carbonyl group (C═O) or a group C═S; X is C═O, C═S, S═O or O═S═O; Y is O, S, C═O, CH 2 , —N(R 8 )—, —O—N(R 8 )—, —N(R 8 )—O— or NH—; R 7  is hydrogen, C 1 –C 4 -alkyl, C 3 –C 4 -alkenyl, C 3 –C 4 -alkynyl, —CH 2 OR 8 , CH 2 SR 8 , —C(O)R 8 , —C(O)OR 8 , SO2R 8 , SOR 8  or SR 8 ; and R 8  is C 1 –C 8 -alkyl, C 1 –C 8 -alkoxyalkyl, C 1 –C 8  haloalkyl or phenylC 1 –C 2 -alkyl wherein the phenyl may be substituted by up to three groups selected from halo or C 1 –C 4 -alkyl; or a salt thereof. The invention also relates to the preparation of the compounds and to agrochemical compositions comprising at least one of those compounds as active ingredient as well as the preparation of the said compositions and to the use of the compounds or of the compositions in controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi.

This application is a 371 of International Application No. PCT/IB01/02821, filed Dec. 20, 2001 and which claims priority to GB 0100102.3, filed Jan. 3, 2001, the contents of which are incorporated herein by reference.

The present invention relates to novel N-phenyl-[4-(4-pyridyl)-pyrimidin-2-yl]-amine derivatives, to a method of protecting plants against attack or infestation by phytopathogenic organisms, such as nematodes or insects or especially microorganisms, preferably fungi, bacteria and viruses, or combinations of two or more of these organisms, by applying a N-phenyl-[4-(4-pyridyl)-pyrimidin-2-yl]-amine derivative as specified hereinafter to a part and/or to the site of a plant, to the use of said derivative for protecting plants against said organisms, and to compositions comprising said derivative as the active component. The invention further relates to the preparation of these novel N-phenyl-[4-(4-pyridyl)-pyrimidin-2-yl]-amine derivatives.

Certain N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives have been described in the art, e.g. in the PCT patent applications WO 95/09851 and WO 95/09853, as having pharmacological properties, mainly as tumor-inhibiting anti-cancer substances.

Surprisingly, it has now been found that the new N-phenyl-[4-(4-pyridyl)-pyrimidin-2-yl]-amines are effective in plant protection and related areas, showing advantageous properties in the treatment of plant diseases caused by organisms.

The novel N-phenyl-[4-(4-pyridyl)-pyrimidin-2-yl]-amine derivatives according to the invention are those of the formula I

wherein

-   the sum of (m+p) together is 0, 1, 2 or 3; -   n and q are independently of each other 0 or 1, and the sum of     (m+p+q) together is 1, 2, 3 or 4; -   R₁ is hydrogen, halogen, alkoxy, haloalkyl, haloalkoxy or alkyl; -   R₂ is hydrogen, C₁–C₆-alkyl, C₁–C₆-haloalkyl or C₁–C₆-alkoxy; -   R_(2A) is hydrogen, C₁–C₆-alkyl, C₃–C₄-alkenyl or C₃–C₄-alkynyl; -   each of R₃, R₄, R₅ and R₆ is, independently of the others, hydrogen,     C₁–C₆-alkyl, C₁–C₆-haloalkyl, hydroxy-C₁–C₆-alkyl or     C₁–C₆-alkoxy-C₁–C₆-alkyl, or the ring members CR₃R₄ or CR₅R₆ or     CR₂R₂A are independently of each other a carbonyl group (C═O) or a     group C═S; -   X is C═O, C═S, S═O or O═S═O; -   Y is O, S, C═O, CH₂, —N(R₈)—, —O—N(R₈)—, —N(R₈)—O— or —NH—; -   R₇ is hydrogen, C₁–C₄-alkyl, C₃–C₄-alkenyl, C₃–C₄-alkynyl, —CH₂OR₈,     CH₂SR₈, —C(O)R₈, —C(O)OR₈, SO2R₈, SOR₈ or SR₈; and -   R₈ is C₁–C₈-alkyl, C₁–C₈-alkoxyalkyl, C₁–C₈ haloalkyl or     phenylC₁–C₂-alkyl wherein the phenyl may be substituted by up to     three groups selected from halo or C₁–C₄-alkyl; or a salt thereof.

The general symbols and expressions used above preferably are defined as below:

Halogen is fluorine, bromine, iodine or preferably chlorine.

Haloalkyl is preferably C₁–C₆-alkyl, more preferably lower alkyl, that is linear or branched and is substituted by one or more, for example in the case of halo-ethyl up to five, halogen atoms, especially fluorine. An example is trifluoromethyl.

Haloalkoxy is preferably C₁–C₆-alkoxy, more preferably lower alkoxy, that is linear or branched and that is substituted by one or more, for example in the case of halo-ethyl up to five, halogen atoms, especially fluorine; trifluoromethoxy and 1,1,2,2-tetrafluoroethoxy are especially preferred.

Alkyl—as a group per se and as a structural element of hydroxyalkyl, alkoxy, alkenyl, alkynyl or haloalkoxy—is preferably C₁–C₆-alkyl, more preferably lower alkyl, and is linear i.e. methyl, ethyl, propyl, butyl, pentyl or hexyl, or branched, e.g. isopropyl, isobutyl, sec.-butyl, tert.-butyl, isopentyl, neopentyl or isohexyl. Lower alkyl is preferably methyl or ethyl. Specific examples of alkenyl and alkynyl include allyl, 2-butenyl, 3-butenyl, propargyl, 2-butinyl and 3 butynyl.

Preferred among the compounds to be used according to the invention is a compound wherein within the N-linked heterocycle attached to the 2-position of the pyridine ring, namely the moiety

is one in which the sum of the index numbers m+p+q is 2, 3 or 4, thus indicating various 5- to 7-membered ring systems, which are conceivable under the given definitions and which are common in the art of heterocycles. More preferably, this moiety represents a 5- and 6-membered ring system (m+p+q is 2 or 3), preferably a 5-membered ring system. Thus examples of the moieties include N-oxazolidin-2-one, N-oxazolidin-2-thione, N-[1,2,3]oxathiazolidine-2-oxide, N-[1,2,3]oxathiazolidine-2,2-dioxide, N-pyrrolidin-2-one, N-pyrrolidin-2-thione, N-pyrrolidine-2,5-dione, N-thiazolidin-2-one, N-4-methylene-oxazolidin-2-one, N-piperidine-2,6-dione, N-morpholine-2,3-dione, N-morpholine-2,5-dione, N-imidazolidin-2-one, N-[[1,2,4]-oxazolidin-5-one, N-1,2,4]-oxazolidin-3-one, N-[1,2,5]oxadiazinan-6-one, N-[1,2,4]oxadiazinan-3-one, azepan-2-one or [1,3]oxazinan-2-one.

More preferred ring systems for the moiety positioned at the 2-position of the pyridyl ring are those selected from the group comprising N-oxazolidin-2-one, N-oxazolidin-2-thione, N-[1,2,3]oxathiazolidine-2-oxide and N-pyrrolidin-2-one.

The compounds of formula I can form acid addition salts, for example with inorganic acids, such as hydrochloric acid, sulfuric acid or a phosphoric acid, or with suitable organic carboxylic or sulfonic acids, for example aliphatic mono- or di-carboxylic acids, such as trifluoroacetic acid, acetic acid, propionic acid, glycolic acid, succinic acid, maleic acid, fumaric acid, hydroxymaleic acid, malic acid, tartaric acid, citric acid, oxalic acid or amino acids, such as arginine or lysine, aromatic carboxylic acids, such as benzoic acid, 2-phenoxy-benzoic acid, 2-acetoxy-benzoic acid, salicylic acid, 4-aminosalicylic acid, aromatic-aliphatic carboxylic acids, such as mandelic acid or cinnamic acid, heteroaromatic carboxylic acids, such as nicotinic acid or isonicotinic acid, aliphatic sulfonic acids, such as methane-, ethane- or 2-hydroxy-ethane-sulfonic acid, or aromatic sulfonic acids, for example benzene-, p-toluene- or naphthalene-2-sulfonic acid.

The pyridine-N-oxides of formula I can form acid addition salts with strong acids, such as hydrochloric acid, nitric acid, phosphoric acid or sulfonic acids, such as benzenesulfonic acid.

Formula I according to the invention shall include all the possible isomeric forms, as well as mixtures, e.g. racemic mixtures, and any mixtures of rotamers.

In view of the close relationship between the compounds of formula I in free form and in the form of their salts, including also salts that can be used as intermediates, for example in the purification of the compounds of formula I or in order to identify those compounds, herein-before and hereinafter any reference to the (free) compounds is to be understood as including also the corresponding salts, where appropriate and expedient.

Among the compounds of formula I according to the present invention the following groups of compounds are preferred. These groups are those wherein

-   R₁ is chlorine, fluorine, trifluoromethyl, trifluoromethoxy, or     1,1,2,2-tetrafluoroethoxy, or -   R₁ is chlorine, or -   R₂ is hydrogen, methyl, trifluoromethyl or ethyl, or -   R₂ is methyl or trifluoromethyl, or -   R₂ is methyl, or -   R_(2A) is hydrogen or methyl; or -   R_(2A) is hydrogen; or -   R₃, R₄, R₅ and R₈ independently of each other are hydrogen, methyl,     hydroxymethyl, hydroxyethyl, or methoxyethyl, or -   one of R₃ and R₄ or one of R₅ and R₆ is hydrogen or methyl, while     the other one is hydrogen, methyl, hydroxymethyl, hydroxyethyl, or     methoxyethyl, or -   R₃ and R₄ are hydrogen, or -   R₅ and R₆ independently of each other are hydrogen or methyl, or -   R₇ is hydrogen, methyl, ethyl, allyl, propargyl, methoxymethyl,     thiomethoxymethyl or ethoxymethyl, or -   R₇ is hydrogen or methoxymethyl, or -   X is carbonyl, C═S, or S═O; or -   X is carbonyl, or -   Y is oxygen, sulfur, —O—N(CH₃)—, or —N(CH₃)—O—, or -   Y is oxygen, or -   X is carbonyl, C═S, or S═O and Y is oxygen. -   n is zero, or -   m is zero and p and q are each one.

Further preferred subgroups comprise those compounds of formula I wherein

-   a) R₁ is chlorine, fluorine, trifluoromethyl, trifluoromethoxy, or     1,1,2,2-tetrafluoroethoxy; R₂ is hydrogen, methyl, trifluoromethyl     or ethyl; R_(2A) is hydrogen or methyl; R₅ and R₆ independently of     each other are hydrogen, methyl, hydroxymethyl, hydroxyethyl, or     methoxyethyl; R₇ is hydrogen, methyl, ethyl, allyl, propargyl, or     methoxymethyl; X is carbonyl, C═S, or S═O; Y is oxygen, sulfur,     —O—N(CH₃)—, or —N(CH₃)—O—; m and n are zero and p and q are each     one; or -   b) R₁ is chlorine; R₂ is methyl or trifluoromethyl; R_(2A) is     hydrogen or methyl; one of R₅ and R₆ is hydrogen or methyl, while     the other one is hydrogen, methyl, hydroxymethyl, hydroxyethyl, or     methoxyethyl; R₇ is hydrogen or methoxymethyl; X is carbonyl; Y is     oxygen; m and n are zero and p and q are each one; or -   c) R₁ is chlorine; R₂ is methyl; R_(2A) is hydrogen; R₅ and R₆     independently of each other are hydrogen or methyl; R₇ is hydrogen     or methoxymethyl; X is carbonyl; Y is oxygen; m and n are zero and p     and q are each one.

Preferred individual compounds of the formula I are:

-   3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-oxazolidin-2-one, -   N-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-pyrrolidin-2-one, -   (3-chloro-phenyl)-{4-[2-(2-oxo-[1,2,3]oxathiazolidin-3-yl)-pyridin-4-yl]-pyrimidin-2-yl}-amine, -   3-{4-[2-(3-fluoro-phenylamino)-pyrimidin-4-yl]-pyrimidin-2-yl}-4-methyl-oxazolidin-2-one, -   3-{4-[2-(3-trifluoromethyl-phenylamino)-pyridin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, -   (3-chloro-phenyl)-{4-[2-(4-methyl-2-oxo-[1,2,3]oxathiazolidin-3-yl)-pyridin-4-yl]-pyrimidin-2-yl}-amine, -   1-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-5-methyl-pyrrolidin-2-one, -   3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-ethyl-oxazolidin-2-one, -   3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-n-propyl-oxazolidin-2-one, -   3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-i-propyl-oxazolidin-2-one, -   3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-5-methyl-oxazolidin-2-one, -   3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, -   3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidine-2-thione, -   (S)-3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, -   3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-trifluoromethyl-oxazolidin-2-one, -   (R)-3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, -   3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-trifluoromethyl-[1,3]oxazinan-2-one -   3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-[1,3]oxazinan-2-one, -   1-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-5-trifluoromethyl-pyrrolidin-2-one, -   3-(4-{2-[(3-chloro-phenyl)-methoxymethyl-amino]-pyrimidin-4-yl}-pyridin-2-yl)-4-methyl-oxazolidin-2-one.

The compounds according to the invention may be prepared according to methods per se known in the art (this does mean, however, that, where novel compounds are produced, the respective process of manufacture is also novel). The procedures for the preparation of compounds of formula I may be outlined as follows:

-   A) reacting a compound of the formula (II)

(or a salt thereof) wherein U is a leaving group, especially halogen, for example fluoro, chloro, bromo or iodo, and the other moieties have the meanings given for a compound of the formula I, with a cyclic amine ring system of the formula III

(or a salt thereof) wherein R₂ to R₆, R_(2A), X, Y, m, p and q have the meanings given for a compound of the formula I, in the presence of a base and a metal catalyst, such as palladium(II) or palladium(O) complexes, or in the presence of a base, such as sodium hydride, potassium carbonate, potassium tert-butoxide or

-   B) cyclize a compound of the formula IV

wherein R₁ to R₇, R_(2A), X, Y, n, m, p and q have the meanings given for a compound of the formula I and U′ is a leaving group, especially halo, for example chloro, bromo or iodo, or sulfonyloxy, for example mesyloxy, trifluoromethansulfonyloxy, tosyloxy or benzenesulfonyloxy by heating it optionally in the presence of a base such as pyridine, triethylamine, sodium carbonate, etc., or

-   C) reacting a compound of the formula V

wherein q is 1 and R₁, R₂, R_(2A), R₅, R₆, R₇, Y, n and p have the meanings given for a compound of the formula I, with phosgene, di- or triphosgene, carbonyldiimidazol, thiophosgene, thiocarbonyldiimidazol or thionylchloride thus obtaining a compound of the subformula Ia

wherein X is C═O, C═S or S═O, q is 1 and R₁, R₂, R_(2A), R₅, R₆, R₇, Y, n and p have the meanings given for a compound of the formula I, or

-   D) by oxidizing of a compound of the subformula Ib

wherein R₁ to R₇, R_(2A), Y, n, m, p and q have the meanings given for a compound of the formula I using an oxidizing amount of an oxidizing agent, for example NaIO₄/RuCl₃, NaOCl/RuO₃ or KMnO₄, in order to form a compound of the formula I, wherein X is O═S═O, or

-   E) reacting a compound of the formula VI

wherein R₁ to R₇, R_(2A), Y, n, m, p and q have the meanings given for a compound of the formula I with an oxidizing amount of an oxidizing agent, for example iodine, in order to form a compound of the formula I, wherein X is S═O.

The reaction types A to E and additional methods which can be applied per se or as analogous procedures for the synthesis of compounds of the formula I are described for example in Organic Letters 2(8), 1101–1104 (2000); Organic Letters 3 (16), 2539–2541 (2001); Organic Letters 2(5), 625–627 (2000); Tetrahedron Letters 40(11), 2035–2038 (1999); Heterocycles 48(3), 481–489 (1998); Journal of Organic Chemistry 55(13), 4156–4162 (1990); Journal of Organic Chemistry 58(3), 696–699 (1993); Journal of Organic Chemistry 50(1), 1–4 (1985); Patent Application GB 2267287 A (1993); Patent Application EP-A-497695 (1992); Organic Magnetic Resonance 12(8), 481–489 (1979); Journal of the Chemical Society, Perkin Trans.2, 1207–1210 (1978); Patent Application JP 54024869 (1979); Yakugaku Zasshi 98(6), 817–821 (1978); Heterocycles 7(2), 919–925 (1977); Chemical Abstracts 77:139931; Zhurnal Organicheskoi Khimii 6(6), 1305–1308 (1970). The palladium catalysts suitable for the C—N linkage reaction (Buchwald-Hartwig amination) of the compound of the formula II with the cyclic amine ring system of the formula III are generally palladium(II) or palladium(0) complexes. They can be prepared in a separate step such as, for example, dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium or PdCl₂(BINAP). The palladium catalyst can also be prepared “in situ” from palladium(II) or palladium(0) compounds, such as, palladium(II) dichloride, palladium(II) acetate, bis(dibenzylideneacetone)palladium(0), tris(dibenzylideneacetone) dipalladium, and corresponding ligands.

Examples of suitable ligands include but are in no way limited to tris(tert-butyl)phosphine, tricyclohexylphosphine (PCy₃), 2,2′-(diphenylphosphino)-bisnaphthalene (BINAP), 1,1′-bis(diphenylphosphino)ferrocene (dppf), 1,1′-bis(di-tert-butylphosphino)ferrocene, 1,2-bis(diphenylphosphino)ethane, 1,3-bis(diphenylphosphino)propane, 1,4-bis(diphenylphosphino)butane, bis(2-(diphenylphosphino)phenyl)ether (DPE-phos), 4,5-bis (diphenylphosphino)-9,9-dimethylxanthanene (Xantphos), 2-(di-tert-butylphosphino)biphenyl, 2-(dicyclohexylphosphino)biphenyl, 2-dicyclohexylphosphino-2′-(N,N′-dimethylamino)biphenyl, 2-di-tert-butylphosphino-2′-(N,N′-dimethylamino)biphenyl.

Exemplary bases include such as, for example, sodium tert-butoxide, potassium tert-butoxide, sodium amide, lithium diusopropyl amide (LDA), lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide, sodium methylate, sodium phenolate, Cs₂CO₃, K₃PO₄.

The compounds of the formula II, V and VI may be prepared in accordance with manufacturing processes described in WO 95/09853, or in analogy to the methods described therein.

The compounds of the formula III are known or may be prepared in analogy to the synthesis methods described in Organic Letters 2(5), 625–627 (2000); Patent Application EP-A-350002 (1990) or in the above mentioned literature.

The compounds of the formula IV are novel und may be prepared by reacting a compound of the formula VII

wherein R₁, R₇ and n have the meanings given for a compound of the formula I, with a compound of the formula VIII

wherein R₂ to R₆, R_(2A), U′, X, Y, m, p and q have the meanings given for a compound of the formula IV and U″ is a leaving group, especially chloro, or is oxygen which forms an anhydride.

The preparation of a compound of the formula VII is described in the PCT application WO 95/09851.

A compound of the formula II, wherein R₇ is hydrogen, may be obtained preferably by reacting a compound of the formula IX

(or—if n is 0—a salt thereof) wherein L is a leaving group, especially alkoxy, such as lower alkoxy, esterified OH (especially tosyloxy), or di-(lower alkylamino), U is a leaving group (preferably halo, such as chloro, bromo or iodo) and n is 0 or 1, with a guanidino compound of the formula X,

(or a salt thereof) wherein R₁ is as defined for a compound of the formula I. The reaction preferably in conducted under conditions analogous to those mentioned in PCT application WO 95/09583, that is, in a suitable solvent or suspending agent, for example a suitable alcohol, such as isopropanpol, or 2-butanol, at a temperature from room temperature (approximately +20° C.) to +150° C., e.g. under reflux.

A compound of the formula II, wherein R₇ is —CH₂OR₈, —C(O)R₈ or —C(O)OR₈, may preferably be obtained by reacting a compound of the formula II, wherein R₇ is hydrogen, with one of the following reagents: Hal-CH₂OR₈, Hal-C(O)R₈, Hal-C(O)OR₈ rasp. O(C(O)R₈)₂, wherein Hal means halogen like chlorine, bromine or iodine.

The compound of the formula IX are known or may be obtained in accordance with methods that are known in the art, e.g. by reacting a compound of the formula XI

wherein n is 0 or 1 and wherein U is a leaving group, preferably as defined for a compound of the formula (IX), either (i) under Claisen or analogue condensation reaction conditions (leading to a free hydroxy instead of the leaving group L in a compound of the formula IX; this free hydroxy group can then be converted into a leaving group, for example by ether formation with an alkylalkohol (“Alkoxy-H”;), yielding alkoxy as L, such as lower alkoxy, or by reaction with an acid or an active ester derivative, e.g. an acid chloride, yielding esterified OH (especially tosyloxy); or to alkoxy L, depending on the reaction conditions), or (ii) preferably by reaction with an N,N-di-(lower alkyl)-formamide di-lower alkylacetal, especially N,N-di-(methyl)formamide di-methylacetal, analogous to the procedure described in European Patent Application EP-A-0233461, which is incorporated by reference, e.g. by reaction in the respective N,N-di-(lower alkyl)-formamide di-lower alkylacetal at a temperature between room temperature and the boiling point of the reaction mixture, especially under reflux conditions.

An intermediate of the formula (XI) may, for example, be obtained by reaction of a metallated methyl derivative of the formula (XII) CH₃-Metal  (XII) wherein Metal stands preferably for Mg-Hal (Hal=halogen) or Li, with a 4-pyridyl-carbonic acid derivative of the formula (XIII)

wherein U and n have the meanings given for a compound of the formula IX, and W is a leaving group, preferably N-lower alkyl-N-lower alkoxy-amino or halogen, under standard conditions for alkylation reactions.

Alternatively, an intermediate of the formula XI, wherein n is 0, may be obtained by reaction of a metallated pyridine derivative of the formula XIV

wherein U is a leaving group, preferably as defined for a compound of the formula IX, and Metal stands for Mg-Hal (Hal=halogen) or Li, under standard conditions for alkylation reactions with an acetyl equivalent of the formula XV

wherein Z is halo, or forms with the rest of the molecule an amide, an alkoxyamide, an anhydride or the like; or Z is hydrogen (meaning that the compound XV is acetaldehyde), resulting after the reaction in an alcohol that is then oxidized with a selective oxidant, for example in the presence of oxalylchloride and dimethyl sulfoxide, to the ketone intermediate of the formula XI.

A starting material of the formula X may be prepared (preferably obtaining an acid addition salt) by reaction of an aniline derivative of the formula XVI

wherein R₁ is as defined for a compound of formula I, with cyanamide (NC-NH₂) in a suitable solvent, e.g. an alcohol, such as a lower alkanol, for example (i) in the presence of equimolar amounts of the salt-forming acid, for example nitric acid, or (ii) in the presence of a clear, for example 60%, excess of a mineral acid, such as hydrochloric acid, where an ammonium salt of the desired salt-forming acid is added when the reaction is complete; at a temperature between room temperature and +150° C., e.g. under reflux.

Compounds of the formulae XIII, XIV and XVI may be prepared according to methods that are known in the art.

The synthesis of many of the starting materials and intermediates may also be done as described in or in analogy to the processes described in WO 95/09853.

In all intermediates, functional groups that shall not participate in the intended reactions may be protected and deprotected at appropriate stages in order to avoid side reactions—appropriate protecting groups and methods for their introduction and removal can be found e.g. in WO 95/09853.

The present invention also relates to novel starting materials and/or intermediates and to processes for the preparation thereof. The starting materials used and the reaction conditions chosen are preferably such that the compounds shown in this disclosure as being especially preferred or to be used preferably are obtained. Especially preferred among the process conditions are those described in the examples below, or analogous procedures.

The invention also relates to compositions which comprise the compounds of the formula I, or a salt thereof, as an active component, in particular plant-protecting compositions, and also to their use in the agricultural sector or related areas.

Active compounds of the formula I are customarily used in the form of compositions and may be added, simultaneously or successively, to the surface or plant to be treated together with additional active compounds. These additional active compounds may be either fertilizers, trace element-supplying agents or other preparations which influence plant growth. It is also possible, in this context, to use selective herbicides, such as insecticides, fungicides, bactericides, nematicides or molluscicides, or mixtures of several of these preparations, additionally, where appropriate, together with excipients, surfactants or other administration-promoting additives which are customary in formulation technology (designated collectively as carrier materials herein).

Suitable excipients and additives may be solid or liquid and are those substances which are appropriate in formulation techology, for example natural or regenerated minerals, solvents, dispersants, wefting agents, adhesives, thickening agents, binding agents or fertilizers.

A preferred method for applying a compound of formula I, or an agrochemical composition which comprises at least one of these compounds, is administration to the leaves (foliar application). The frequency and rate of administration depend upon the risk of infestation by the corresponding pathogen. The compounds of formula I can, however, also penetrate the plant through the roots via the soil (systemic action). If the locus of the plant is impregnated with a liquid formulation or if the substances are introduced in solid form into the soil, e.g. in the form of granules (soil application). In paddy rice crops, such granules can be applied in metered amounts to the flooded rice fields. In order to treat seeds, the compounds of formula I can, however, also be applied to the seeds (coating), either by impregnating the grains or tubers with a liquid formulation of the active ingredient, or by coating them with a solid formulation.

Advantageous rates of application are in normally from 5 g to 2 kg of active ingredient (a.i.) per hectare (ha), preferably from 10 g to 1 kg of a.i./ha, especially from 20 g to 600 g a.i./ha. When the compound are used as seed dressings, dosages of from 10 mg to 1 g of active ingredient per kg seed are advantageous employed. The agrochemical compositions generally comprise 0.1 to 99% by weight, preferably 0.1 to 95% by weight, of a compound of formula I, 99.9 to 1% by weight, preferably 99.8 to 5% by weight, of a solid or liquid adjuvant and 0 to 25% by weight, preferably 0.1 to 25% by weight, of a surfactant. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.

The compositions may also comprise further auxiliaries, such as fertilizers and other active ingredients for obtaining special desirable biological effects.

The compounds of formula I may be used preventatively and/or curatively in the sector of agronomics and related technical areas as active ingredients for controlling plant pests. The active ingredients of formula I according to the invention are notable for their good activity even at low concentrations, for their good plant tolerance and for their environmentally friendly nature. They have very advantageous, especially systemic, properties and may be used to protect a plurality of cultivated plants. Using the active ingredients of formula I on plants or plant parts (fruit, flowers, leaves, stems, tubers, roots) of various crops, the pests appearing can be controlled or destroyed, whereby the parts of plants which grow later also remain protected, e.g. from phytopathogenic microorganisms.

The compounds I may additionally be used as a dressing to treat seeds (fruits, tubers, corms) and plant cuttings to protect against fungal infections and against phytopathogenic fungi occurring in the soil.

The compounds I are effective for example against the following classes of related phytopathogenic fungi: Fungi imperfecti (e.g. Botrytis, Pyricularia, Helminthosporium, Fusarium, Septoria, Cercospora and Alternaria); Basidiomycetes (e.g. Rhizoctonia, Hemileia, Puccinia); Ascomycetes (e.g. Venturia and Erysiphe, Podosphaera, Monilinia, Uncinula) and Oomycetes (e.g. Phytophthora, Pythium, Plasmopara).

Target crops for the plant-protecting usage in terms of the invention are for example the following plant cultivars: cereals (wheat, barley, rye, oats, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pome, stone and berry fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); legumes (beans, lentils, peas, soya); oil crops (rape, mustard, poppy, olives, sunflowers, coconut, castor oil, cocoa, peanut); cucumber plants (squashes, cucumber, melons); citrus fruits (oranges, lemons, grapefruits, mandarines); vegetables (spinach, lettuce, asparagus, cabbage varieties, carrots, onions, tomatoes, potatoes, paprika); laurels (avocado, cinnamonium, camphor) and plants such as tobacco, nuts, coffee, aubergines, sugar cane, tea, pepper, vines, hops, bananas and natural rubber plants, as well as ornamental plants.

Further areas of application for the active ingredients according to the invention are the protection of stores and material, where the storage matter is protected against putrescence and mould.

The compounds I are used in unchanged form or preferably together with customary excipients in formulation techniques. To this end, they are conveniently processed in known manner e.g. into emulsion concentrates, coatable pastes, directly sprayable or diluable solutions, diluted emulsions, wettable powders, soluble powders, dusts or granules, e.g. by encapsulation into for example polymeric materials. As with the type of medium, the application processes, such as spraying, atomizing, dusting, scattering, coating or pouring are similarly chosen according to the desired aims and the prevailing conditions.

Suitable substrates and additives may be solid or liquid and are useful substances in formulation techniques, e.g. natural or regenerated mineral substances, dissolving aids, dispersants, wetting agents, tackifiers, thickeners or binding agents.

The compounds of formula I may be mixed with further active ingredients, e.g. fertilizers, ingredients providing trace elements or other active ingredients used in the plant protection science, especially further fungicides. In doing so, in some cases synergistic enhancement of the biological effects may occur.

Preferred active ingredients advantageous as additives to the compositions comprising the active ingredient of formula I are:

Azoles, such as azaconazole, BAY 14120, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pyrifenox, prochloraz, propiconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole; pyrimidinyl carbinole, such as ancymidol, fenarimol, nuarimol; 2-amino-pyrimidines, such as bupirimate, dimethirimol, ethirimol; morpholines, such as dodemorph, fenpropidine, fenpropimorph, spiroxamine, tridemorph; anilinopyrimidines, such as cyprodinil, mepanipyrim, pyrimethanil; pyrroles, such as fenpiclonil, fludioxonil; phenylamides, such as benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofurace, oxadixyl; benzimidazoles, such as benomyl, carbendazim, debacarb, fuberidazole, thiabendazole; dicarboximides, such as chlozolinate, dichlozoline, iprodione, myclozoline, procymidone, vinclozoline; carboxamides, such as carboxin, fenfuram, flutolanil, mepronil, oxycarboxin, thifluzamide; guanidines, such as guazatine, dodine, iminoctadine; strobilurines, such as azoxystrobin, kresoxim-methyl, metominostrobin, SSF-129, trifloxystrobin, picoxystrobin, BAS 500F (proposed name pyraclostro-bin), BAS 520; dithiocarbamates, such as ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram; N-halomethylthiotetrahydrophthalimides, such as captafol, captan, dichlofluanid, fluoromides, folpet, tolyfluanid; Cu-compounds, such as Bordeaux mixture, copper hydroxide, copper oxychloride, copper sulfate, cuprous oxide, mancopper, oxine-copper; nitrophenol-derivatives, such as dinocap, nitrothal-isopropyl; organo-p-derivatives, such as edifenphos, iprobenphos, isoprothiolane, phosdiphen, pyrazophos, tolclofos-methyl; various others, such as acibenzolar-S-methyl, anilazine, benthiavalicarb, blasticidin-S, chinomethionate, chloroneb, chlorothalonil, cyflufenamid, cymoxanil, dichlone, diclomezine, dicloran, diethofencarb, dimethomorph, SYP-LI90 (proposed name: flumorph), dithianon, ethaboxam, etridiazole, famoxadone, fenamidone, fenoxanil, fentin, ferimzone, fluazinam, flusulfamide, fenhexamid, fosetyl-aluminium, hymexazol, iprovalicarb, IKF-916 (cyazofamid), kasugamycin, methasulfocarb, metrafenone, nicobifen, pencycuron, phthalide, polyoxins, probenazole, propamocarb, pyroquilon, quinoxyfen, quintozene, sulfur, triazoxide, tricyclazole, triforine, validamycin, zoxamide (RH7281).

One preferred method of application of an active ingredient of formula I or of an agrochemical composition containing at least one of these active ingredients is foliar application. The frequency and amount of application depend on the severity of the attack by the pathogen in question. However, the active ingredients I may also reach the plants through the root system via the soil (systemic action) by drenching the locus of the plant with a liquid preparation or by incorporating the substances into the soil in solid form, e.g. in the form of granules (soil application). In rice cultivations, these granules may be dispensed over the flooded paddy field. The compounds I may however also be applied to seed grain to treat seed material (coating), whereby the grains or tubers are either drenched in a liquid preparation of the active ingredient or coated with a solid preparation.

The compositions are produced in known manner, e.g. by intimately mixing and/or grinding the active ingredient with extenders such as solvents, solid carriers and optionally surfactants.

Favourable application rates are in general 1 g to 2 kg of active substance (AS) per hectare (ha), preferably 10 g to 1 kg AS/ha, especially 20 g to 600 g AS/ha. For usage as a seed dressing, it is advantageous to use dosages of 10 mg to 1 g active substance per kg of seed grain.

While concentrated compositions are preferred for commercial usage, the end user normally uses diluted compositions.

Formulations may be prepared analogously to those described for example in WO 97/33890.

EXAMPLES

The subsequent examples are intended to illustrate the invention, without however limiting the scope thereof.

Synthesis Example 1 3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-oxazolidin-2-one

Phosgene in toluene (1.9 ml of a 20% commercial solution, 3.5 mmol) is added within five minutes to a solution of 2-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-ylamino}-ethanol (0.88 g, 2.6 mmol) and triethylamine (1.7 ml, 11.7 mmol) in absolute THF (20 ml) at 50° C. After stirring the resulting suspension for one hour at room temperature it is partitioned between ethyl acetate and water. The organic phase is separated, dried over magnesium sulfate, filtered and evaporated under reduced presssure. The residue is purified by silicagel chromatography to give the title compound, m.p. 162–163° C.

Synthesis Example 2 3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl-pyridin-2-yl}-oxazolidine-2-thione

A mixture of 2-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-ylamino}-ethanol (0.67 g, 2.0 mmol) and thiocarbonyldiimidazole (0.38 g, 2.1 mmol) in absolute THF (20 ml) is stirred at room temperature for one hour. The reaction mixture is partitioned between ethyl acetate and water. The organic phase is separated, dried over magnesium sulfate, filtered and evaporated under reduced presssure. The residue is purified by silicagel chromatography to give the title compound, m.p. 213–214° C.

Synthesis Example 3 (3-Chloro-phenyl)-{4-[2-(2-oxo-[1,2,3]oxathiazolidin-3-yl)-pyridin-4-yl]-pyrimidin-2-yl}-amine

A solution of sulfonyl chloride (0.63 g, 5.3 mmol) in THF (2 ml) is added within 5 minutes to a solution of 2-{4-(2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-ylamino}-ethanol (1.50 g, 4.4 mmol) and triethylamine (3.0 ml, 22 mmol) in absolute THF (20 ml) at +5° C. After stirring the resulting suspension for four hours at room temperature it is partitioned between ethyl acetate and water. The organic phase is separated, dried over magnesium sulfate, filtered and evaporated under reduced presssure. The residue is purified by silicagel chromatography to give the title compound, m.p. 202–203° C.

Synthesis Example 4 1-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-pyrrolidin-2-one

To a solution of (3-chloro-phenyl)-[4-(2-chloro-pyridin-4-yl)-pyrimidin-2-yl]-amine (4.8 g, 0.015 mol) in pyrrolidon (20 ml) is added sodium hydride (1.93 g, 0.06 mmol of a 75% dispersion in oil) in several portions. The reaction temperature is slowly raised to +150° C. After 30 minutes the heating bath is removed and the mixture is poured onto crushed ice. The reaction mixture is partitioned between ethyl acetate and water. The organic phase is separated, dried over magnesium sulfate, filtered and evaporated under reduced presssure. The residue is purified by silicagel chromatography and recrystallized from ethyl acetate to give the title compound, m.p. 165–166° C.

Synthesis Example 5 3-(4-{2-[(3-Chloro-phenyl)-methoxymethyl-amino]-pyrimidin-4-yl}-pyridin-2-yl)-4-methyl-oxazolidin-2-one

Potassium t-butoxide (0.235 g, 2.1 mmol) is added at room temperature to a solution of 3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one (0.5 g, 1.3 mmol). After stirring the mixture for 10 minutes chloromethylmethylether (0.17 g, 2.1 mmol) in THF (3 ml) is added. The mixture is stirred for additional 5 hours at this temperature. Dilution with ethyl acetate, washing with brine, drying over magnesium sulfate, filtering and evaporation of the solvent gives the title compound in form of a slightly colored oil; ¹H-NMR (DMSO): 8.70 (s, 1H); 8.51 (d, 1H); 8.48 (d, 1H); 7.68 (d, 1H); 7.47–7.23 (m, 5H); 5.39 (s,2H); 4.87–4.74 (m,1H); 4.50 (dd, 1H); 4.08 (dd,1H); 3.25 (s,3H); 1.33 (d,3H).

Synthesis Example 6 1-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-5-methyl-pyrrolidin-2-one

In a Schlenk tube (3-chloro-phenyl)-[4-(2-chloro-pyridin-4-yl)-pyrimidin-2-yl]-amine (0.95 g), NaOtBu (0.29 g), dppf (0.1 g), Pd(OAc)₂ (0.01 g) and 4-methylpyrrolidin-2one (0.2 g) are added: Three consecutive cycles of vacuum/argon are applied. Thereafter, 10 ml of degassed dioxane is added and the solution is heated to 120° C. (external temperature) for 8 hours. The solvent is removed under vacuum and the crude product is purified over column chromatography (eluent; EE/MeOH=9/1) yielding the title compound, m.p. 162–164° C.

Synthesis Example 7 3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one

A solution of Xantphos (0.018 g) and Pd₂(dba)₃ (0.014 g) in toluene (2 ml) is stirred under argon at room temperature for 20 minutes. Then (3-chloro-phenyl)-[4-(2-chloro-pyridin-4-yl)-pyrimidin-2-yl]-amine (0.20 g), (R)-4-methyl-oxazolidin-2-one (0.127 g), NaOtBu (0.085 g) and toluene ((2 ml) are added. The reaction mixture is refluxed at 120° C. for 1 hour. After this time the mixture is cooled to room temperature, diluted with ethyl acetate, and washed with water. The organic layer is dried over Na₂SO₄ and concentrated under vacuum. The residue is purified by silicagel chromatography to give the title compound, m.p. 177–178° C. and [α]_(D)=−72.0° (20° C., c=1).

Similar to the above described working examples the compounds of the following tables may be obtained.

Table 1

Compounds of the general structure I.1, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 2

Compounds of the general structure I.2, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 3

Compounds of the general structure I.3, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 4

Compounds of the general structure I.4, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 5

Compounds of the general structure I.5, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 6

Compounds of the general structure I.5, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 7

Compounds of the general structure I.7, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 8

Compounds of the general structure I.8, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 9

Compounds of the general structure I.9, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 10

Compounds of the general structure I.10, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 11

Compounds of the general structure I.11, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 12

Compounds of the general structure I.12, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 13

Compounds of the general structure I.13, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 14

Compounds of the general structure I.14, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 15

Compounds of the general structure I.15, wherein R₂–R₈, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 16

Compounds of the general structure I.16, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 17

Compounds of the general structure I.17, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 18

Compounds of the general structure I.18, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 19

Compounds of the general structure I.19, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table 20

Compounds of the general structure I.20, wherein R₂–R₆, R_(2A), X, Y, m, p and q correspond with a line of table A.

Table A:

No. R₂ R_(2A) R₃ R₄ R₅ R₆ X Y m p q 001 H H H H C═O O 0 1 1 002 CH₃ H H H C═O O 0 1 1 003 CH₂CH₃ H H H C═O O 0 1 1 004 (CH₂)₂CH₃ H H H C═O O 0 1 1 005 CH(CH₃)₂ H H H C═O O 0 1 1 006 H H CH₃ H C═O O 0 1 1 007 CH₃ H CH₃ H C═O O 0 1 1 008 CH₃ H CH₂OH H C═O O 0 1 1 009 CH₃ H (CH₂)₂OH H C═O O 0 1 1 010 CH₃ H CH₂OCH₃ H C═O O 0 1 1 011 CH₃ H (CH₂)₂OCH₃ H C═O O 0 1 1 012 H H CH₃ CH₃ C═O O 0 1 1 013 CH₃ H CH₃ CH₃ C═O O 0 1 1 014 CH₂CH₃ H CH₃ CH₃ C═O O 0 1 1 015 H H H H C═S O 0 1 1 016 H H CH₃ H C═S O 0 1 1 017 CH₃ H H H C═S O 0 1 1 018 CH₂CH₃ H H H C═S O 0 1 1 019 CH₃ H CH₃ H C═S O 0 1 1 020 CH₂CH₃ H CH₃ H C═S O 0 1 1 021 CH₃ H CH₃ CH₃ C═S O 0 1 1 022 CH₂CH₃ H CH₃ CH₃ C═S O 0 1 1 023 H H H H S═O O 0 1 1 024 CH₃ H H H S═O O 0 1 1 025 CH₂CH₃ H H H S═O O 0 1 1 026 CH₃ H CH₃ H S═O O 0 1 1 027 CH₂CH₃ H CH₃ H S═O O 0 1 1 028 CH₃ H CH₃ CH₃ S═O O 0 1 1 029 CH₂CH₃ H CH₃ CH₃ S═O O 0 1 1 030 CH₃ H H H O═S═O O 0 1 1 031 CH₂CH₃ H H H O═S═O O 0 1 1 032 CH₃ H CH₃ H O═S═O O 0 1 1 033 CH₂CH₃ H CH₃ H O═S═O O 0 1 1 034 CH₃ H CH₃ CH₃ O═S═O O 0 1 1 035 CH₂CH₃ H CH₃ CH₃ O═S═O O 0 1 1 036 CH₃ H H H C═O S 0 1 1 037 CH₂CH₃ H H H C═O S 0 1 1 038 CH₃ H CH₃ H C═O S 0 1 1 039 CH₂CH₃ H CH₃ H C═O S 0 1 1 040 CH₃ H CH₃ CH₃ C═O S 0 1 1 041 CH₂CH₃ H CH₃ CH₃ C═O S 0 1 1 042 H H H H C═O O 1 0 1 043 CH₃ H H H C═O O 1 0 1 044 CH₂CH₃ H H H C═O O 1 0 1 045 H H CH₃ H C═O O 1 0 1 046 CH₃ H CH₃ H C═O O 1 0 1 047 CH₂CH₃ H CH₃ H C═O O 1 0 1 048 CH₃ H CH₂OH H C═O O 1 0 1 049 CH₃ H (CH₂)₂OH H C═O O 1 0 1 050 CH₃ H CH₂OCH₃ H C═O O 1 0 1 051 CH₃ H (CH₂)₂OCH₃ H C═O O 1 0 1 052 H H CH₃ CH₃ C═O O 1 0 1 053 CH₃ H CH₃ CH₃ C═O O 1 0 1 054 CH₂CH₃ H CH₃ CH₃ C═O O 1 0 1 055 CH₃ H H H C═S O 1 0 1 056 CH₂CH₃ H H H C═S O 1 0 1 057 CH₃ H CH₃ H C═S O 1 0 1 058 CH₂CH₃ H CH₃ H C═S O 1 0 1 059 CH₃ H CH₃ CH₃ C═S O 1 0 1 060 CH₂CH₃ H CH₃ CH₃ C═S O 1 0 1 061 CH₃ H H H S═O O 1 0 1 062 CH₂CH₃ H H H S═O O 1 0 1 063 CH₃ H CH₃ H S═O O 1 0 1 064 CH₂CH₃ H CH₃ H S═O O 1 0 1 065 CH₃ H CH₃ CH₃ S═O O 1 0 1 066 CH₂CH₃ H CH₃ CH₃ S═O O 1 0 1 067 CH₃ H H H O═S═O O 1 0 1 068 CH₂CH₃ H H H O═S═O O 1 0 1 069 CH₃ H CH₃ H O═S═O O 1 0 1 070 CH₂CH₃ H CH₃ H O═S═O O 1 0 1 071 CH₃ H CH₃ CH₃ O═S═O O 1 0 1 072 CH₂CH₃ H CH₃ CH₃ O═S═O O 1 0 1 073 CH₃ H H H C═O S 1 0 1 074 CH₂CH₃ H H H C═O S 1 0 1 075 CH₃ H CH₃ H C═O S 1 0 1 076 CH₂CH₃ H CH₃ H C═O S 1 0 1 077 CH₃ H CH₃ CH₃ C═O S 1 0 1 078 CH₂CH₃ H CH₃ CH₃ C═O S 1 0 1 079 H H H H H H C═O 1 1 0 080 CH₃ H H H H H C═O 1 1 0 081 CH₂CH₃ H H H H H C═O 1 1 0 082 H H CH₃ H H H C═O 1 1 0 083 CH₃ H CH₃ H H H C═O 1 1 0 084 CH₂CH₃ H CH₃ H H H C═O 1 1 0 085 CH₃ H CH₂OH H H H C═O 1 1 0 086 CH₃ H (CH₂)₂OH H H H C═O 1 1 0 087 CH₃ H CH₂OCH₃ H H H C═O 1 1 0 088 CH₃ H (CH₂)₂OCH₃ H H H C═O 1 1 0 089 H H CH₃ CH₃ H H C═O 1 1 0 090 CH₃ H CH₃ CH₃ H H C═O 1 1 0 091 CH₂CH₃ H CH₃ CH₃ H H C═O 1 1 0 092 H H H H CH₃ H C═O 1 1 0 093 CH₃ H H H CH₃ H C═O 1 1 0 094 CH₂CH₃ H H H CH₃ H C═O 1 1 0 095 CH₃ H H H CH₂OH H C═O 1 1 0 096 CH₃ H H H (CH₂)₂OH H C═O 1 1 0 097 CH₃ H H H CH₂OCH₃ H C═O 1 1 0 098 CH₃ H H H (CH₂)₂OCH₃ H C═O 1 1 0 099 H H H H CH₃ CH₃ C═O 1 1 0 100 CH₃ H H H CH₃ CH₃ C═O 1 1 0 101 CH₂CH₃ H H H CH₃ CH₃ C═O 1 1 0 102 H H CH₃ H CH₃ H C═O 1 1 0 103 CH₃ H CH₃ H CH₃ H C═O 1 1 0 104 CH₂CH₃ H CH₃ H CH₃ H C═O 1 1 0 105 CH₃ H CH₃ CH₃ CH₃ H C═O 1 1 0 106 CH₂CH₃ H CH₃ CH₃ CH₃ H C═O 1 1 0 107 CH₃ H CH₃ H CH₃ H C═O 1 1 0 108 CH₂CH₃ H CH₃ H CH₃ H C═O 1 1 0 109 CH₃ H CH₃ CH₃ CH₃ CH₃ C═O 1 1 0 110 CH₂CH₃ H CH₃ CH₃ CH₃ CH₃ C═O 1 1 0 111 CH₃ H H H H H C═S 1 1 0 112 CH₂CH₃ H H H H H C═S 1 1 0 113 CH₃ H CH₃ H H H C═S 1 1 0 114 CH₂CH₃ H CH₃ H H H C═S 1 1 0 115 CH₃ H CH₃ CH₃ H H C═S 1 1 0 116 CH₂CH₃ H CH₃ CH₃ H H C═S 1 1 0 117 CH₃ H H H CH₃ H C═S 1 1 0 118 CH₂CH₃ H H H CH₃ H C═S 1 1 0 119 CH₃ H CH₃ H CH₃ H C═S 1 1 0 120 CH₂CH₃ H CH₃ H CH₃ H C═S 1 1 0 121 CH₃ H CH₃ CH₃ CH₃ H C═S 1 1 0 122 CH₂CH₃ H CH₃ CH₃ CH₃ H C═S 1 1 0 123 CH₃ H H H CH₃ CH₃ C═S 1 1 0 124 CH₂CH₃ H H H CH₃ CH₃ C═S 1 1 0 125 CH₃ H CH₃ H CH₃ CH₃ C═S 1 1 0 126 CH₂CH₃ H CH₃ H CH₃ CH₃ C═S 1 1 0 127 CH₃ H CH₃ CH₃ CH₃ CH₃ C═S 1 1 0 128 CH₂CH₃ H CH₃ CH₃ CH₃ CH₃ C═S 1 1 0 129 CH₃ H H H H H S═O 1 1 0 130 CH₂CH₃ H H H H H S═O 1 1 0 131 CH₃ H CH₃ H H H S═O 1 1 0 132 CH₂CH₃ H CH₃ H H H S═O 1 1 0 133 CH₃ H CH₃ CH₃ H H S═O 1 1 0 134 CH₂CH₃ H CH₃ CH₃ H H S═O 1 1 0 135 CH₃ H H H CH₃ H S═O 1 1 0 136 CH₂CH₃ H H H CH₃ H S═O 1 1 0 137 CH₃ H CH₃ H CH₃ H S═O 1 1 0 138 CH₂CH₃ H CH₃ H CH₃ H S═O 1 1 0 139 CH₃ H CH₃ CH₃ CH₃ H S═O 1 1 0 140 CH₂CH₃ H CH₃ CH₃ CH₃ H S═O 1 1 0 141 CH₃ H H H CH₃ CH₃ S═O 1 1 0 142 CH₂CH₃ H H H CH₃ CH₃ S═O 1 1 0 143 CH₃ H CH₃ H CH₃ CH₃ S═O 1 1 0 144 CH₂CH₃ H CH₃ H CH₃ CH₃ S═O 1 1 0 145 CH₃ H CH₃ CH₃ CH₃ CH₃ S═O 1 1 0 146 CH₂CH₃ H CH₃ CH₃ CH₃ CH₃ S═O 1 1 0 147 CH₃ H H H H H O═S═O 1 1 0 148 CH₂CH₃ H H H H H O═S═O 1 1 0 149 CH₃ H CH₃ H H H O═S═O 1 1 0 150 CH₂CH₃ H CH₃ H H H O═S═O 1 1 0 151 CH₃ H CH₃ CH₃ H H O═S═O 1 1 0 152 CH₂CH₃ H CH₃ CH₃ H H O═S═O 1 1 0 153 CH₃ H H H CH₃ H O═S═O 1 1 0 154 CH₂CH₃ H H H CH₃ H O═S═O 1 1 0 155 CH₃ H CH₃ H CH₃ H O═S═O 1 1 0 156 CH₂CH₃ H CH₃ H CH₃ H O═S═O 1 1 0 157 CH₃ H CH₃ CH₃ CH₃ H O═S═O 1 1 0 158 CH₂CH₃ H CH₃ CH₃ CH₃ H O═S═O 1 1 0 159 CH₃ H H H CH₃ CH₃ O═S═O 1 1 0 160 CH₂CH₃ H H H CH₃ CH₃ O═S═O 1 1 0 161 CH₃ H CH₃ H CH₃ CH₃ O═S═O 1 1 0 162 CH₂CH₃ H CH₃ H CH₃ CH₃ O═S═O 1 1 0 163 CH₃ H CH₃ CH₃ CH₃ CH₃ O═S═O 1 1 0 164 CH₂CH₃ H CH₃ CH₃ CH₃ CH₃ O═S═O 1 1 0 165 CH₃ H C═O H H C═O 1 1 0 166 CH₃ H C═O CH₃ H C═O 1 1 0 167 CH₃ H C═O CH₂OH H C═O 1 1 0 168 CH₃ H C═O CH₂OCH₃ H C═O 1 1 0 169 CH₃ H C═O CH₂OCH₂CH₃ H C═O 1 1 0 170 CH₃ H H H C═O C═O 1 1 0 171 CH₃ H CH₃ H C═O C═O 1 1 0 172 CH₃ H CH₃ CH₃ C═O C═O 1 1 0 173 H H H H C═O NCH₃ 0 1 1 174 CH₃ H H H C═O NCH₃ 0 1 1 175 CH₂CH₃ H H H C═O NCH₃ 0 1 1 176 H H CH₃ H C═O NCH₃ 0 1 1 177 CH₃ H CH₃ H C═O NCH₃ 0 1 1 178 CH₃ H CH₂OH H C═O NCH₃ 0 1 1 179 CH₃ H (CH₂)₂OH H C═O NCH₃ 0 1 1 180 CH₃ H CH₂OCH₃ H C═O NCH₃ 0 1 1 181 CH₃ H (CH₂)₂OCH₃ H C═O NCH₃ 0 1 1 182 H H CH₃ CH₃ C═O NCH₃ 0 1 1 183 CH₃ H CH₃ CH₃ C═O NCH₃ 0 1 1 184 CH₂CH₃ H CH₃ CH₃ C═O NCH₃ 0 1 1 185 CH₃ H H H C═S NCH₃ 0 1 1 186 CH₂CH₃ H H H C═S NCH₃ 0 1 1 187 CH₃ H CH₃ H C═S NCH₃ 0 1 1 188 CH₂CH₃ H CH₃ H C═S NCH₃ 0 1 1 189 CH₃ H CH₃ CH₃ C═S NCH₃ 0 1 1 190 CH₂CH₃ H CH₃ CH₃ C═S NCH₃ 0 1 1 191 CH₃ H H H S═O NCH₃ 0 1 1 192 CH₂CH₃ H H H S═O NCH₃ 0 1 1 193 CH₃ H CH₃ H S═O NCH₃ 0 1 1 194 CH₂CH₃ H CH₃ H S═O NCH₃ 0 1 1 195 CH₃ H CH₃ CH₃ S═O NCH₃ 0 1 1 196 CH₂CH₃ H CH₃ CH₃ S═O NCH₃ 0 1 1 197 CH₃ H H H O═S═O NCH₃ 0 1 1 198 CH₂CH₃ H H H O═S═O NCH₃ 0 1 1 199 CH₃ H CH₃ H O═S═O NCH₃ 0 1 1 200 CH₂CH₃ H CH₃ H O═S═O NCH₃ 0 1 1 201 CH₃ H CH₃ CH₃ O═S═O NCH₃ 0 1 1 202 CH₂CH₃ H CH₃ CH₃ O═S═O NCH₃ 0 1 1 203 H H C═O ON(CH₃) 0 0 1 204 CH₃ H C═O ON(CH₃) 0 0 1 205 CH₂CH₃ H C═O ON(CH₃) 0 0 1 206 H H C═O N(CH₃)O 0 0 1 207 CH₃ H C═O N(CH₃)O 0 0 1 208 CH₂CH₃ H C═O N(CH₃)O 0 0 1 209 H H H H C═O O 0 2 1 210 CH₃ H H H C═O O 0 2 1 211 CH₂CH₃ H H H C═O O 0 2 1 212 (CH₂)₂CH₃ H H H C═O O 0 2 1 213 CH(CH₃)₂ H H H C═O O 0 2 1 214 CH₃ H H H S═O O 0 2 1 215 CH₂CH₃ H H H S═O O 0 2 1 216 CH₃ H H H O═S═O O 0 2 1 217 CH₂CH₃ H H H O═S═O O 0 2 1 218 H H H H C═O O 2 0 1 219 CH₃ H H H C═O O 2 0 1 220 CH₂CH₃ H H H C═O O 2 0 1 221 H H H H H H C═O O 1 1 1 222 CH₃ H H H H H C═O O 1 1 1 223 CH₂CH₃ H H H H H C═O O 1 1 1 224 H H CH₃ H H H C═O O 1 1 1 225 CH₃ H CH₃ H H H C═O O 1 1 1 226 CH₂CH₃ H CH₃ H H H C═O O 1 1 1 227 H H CH₃ CH₃ H H C═O O 1 1 1 228 CH₃ H CH₃ CH₃ H H C═O O 1 1 1 229 CH₂CH₃ H CH₃ CH₃ H H C═O O 1 1 1 230 H H H H CH₃ H C═O O 1 1 1 231 CH₃ H H H CH₃ H C═O O 1 1 1 232 CH₂CH₃ H H H CH₃ H C═O O 1 1 1 233 H H H H CH₃ CH₃ C═O O 1 1 1 234 CH₃ H H H CH₃ CH₃ C═O O 1 1 1 235 CH₂CH₃ H H H CH₃ CH₃ C═O O 1 1 1 236 H H CH₃ H CH₃ H C═O O 1 1 1 237 CH₃ H CH₃ H CH₃ H C═O O 1 1 1 238 CH₂CH₃ H CH₃ H CH₃ H C═O O 1 1 1 239 CH₃ H CH₃ CH₃ CH₃ H C═O O 1 1 1 240 CH₂CH₃ H CH₃ CH₃ CH₃ H C═O O 1 1 1 241 CH₃ H CH₃ H CH₃ H C═O O 1 1 1 242 CH₂CH₃ H CH₃ H CH₃ H C═O O 1 1 1 243 CH₃ H CH₃ CH₃ CH₃ CH₃ C═O O 1 1 1 244 CH₂CH₃ H CH₃ CH₃ CH₃ CH₃ C═O O 1 1 1 245 CH₃ H C═O H H C═O O 1 1 1 246 CH₃ H C═O CH₃ H C═O O 1 1 1 247 CH₃ H C═O CH₃ CH₃ C═O O 1 1 1 248 CH₂CH₃ H C═O H H C═O O 1 1 1 249 CH₃ H H H C═O C═O O 1 1 1 250 CH₃ H CH₃ H C═O C═O O 1 1 1 251 CH₃ H CH₃ CH₃ C═O C═O O 1 1 1 252 CH₃ H H H C═O NH 0 1 1 253 CH₃ CH₃ H H C═O NH 0 1 1 254 H H H H C═O NH 0 1 1 255 CH₃ H H H C═S NH 0 1 1 256 H H H H C═S NH 0 1 1 257 CH₃ H CH₃ H C═O NH 0 1 1 258 CH₂CH₃ H H H C═O NH 0 1 1 259 CH₂CH₃ H H H C═S NH 0 1 1 260 CH₃ CH₃ H H C═O O 0 1 1 261 CH₃ CH₃ H H H H C═O O 1 1 1 262 CH₃ CH₃ H H C═S O 0 1 1 263 CH₃ CH₃ H H S═O O 0 1 1 264 CH₃ CH₃ H H O═S═O O 0 1 1 265 CH₃ CH₃ H H C═O S 0 1 1 266 CH₃ CH₂CH₃ H H C═O O 0 1 1 267 CH₃ CH₂CH₃ H H C═O S 0 1 1 268 CH₃ CH₂CH₃ H H C═O NCH₃ 0 1 1 269 CH₃ CH₂CH₃ H H C═S O 0 1 1 270 CH₃ CH₂CH₃ H H O═S═O O 0 1 1 271 CH₃ CH₃ H H C═O O 0 2 1 272 CH₃ CH₂CH₂CH₃ H H C═O O 0 1 1 273 CH₃ CH₃ C═O H H C═O O 1 1 1 274 CH₃ CH₃ CH₃ H C═O O 0 1 1 275 C═O H H H H C═O 1 1 0 276 C═O CH₃ H C═O O 0 1 1 277 C═O CH₃ H H H C═O 1 1 0 278 C═O CH₃ H CH₃ H C═O 1 1 0 279 C═O CH₂CH₃ H CH₂CH₃ H C═O 1 1 0 280 C═O H H CH₃ H C═O 1 1 0 281 C═O CH₃ H CH₃ H C═O CH₂ 1 1 1 282 C═O H H CH₃ H C═O CH₂ 1 1 1 283 C═O CH₃ H H H C═O CH₂ 1 1 1 284 C═O H H H H C═O CH₂ 1 1 1 285 C═O CH₂CH₃ H CH₂CH₃ H C═O CH₂ 1 1 1 286 C═O CH₂CH₃ H H H C═O CH₂ 1 1 1 287 C═O H H CH₂CH₃ H C═O CH₂ 1 1 1 288 CF₃ H H H C═O O 0 1 1 289 CF₃ H H H H H C═O 1 1 0 290 CF₃ H H H H H C═O 2 1 0 291 CF₃ H H H H H C═O O 1 1 1 292 CF₃ H H H CH₃ H C═O 1 1 0 293 CF₃ H CH₃ H C═O O 0 1 1 294 CF₃ H H H S═O O 0 1 1 295 CF₃ H H H H H C═O CH₂ 2 1 1 296 CH₃ H H H H H C═O CH₂ 2 1 1 297 CH₃ H H H H H S═O CH₂ 2 1 1 298 CH₃ H H H CH₃ H C═S CH₂ 2 1 1 299 CH₂CH₂CH₃ H H H H H C═O CH₂ 2 1 1 300 CH₃ CH₃ H H CH₃ H C═O CH₂ 2 1 1 301 CF₃ H H H C═O O 0 2 1 For the following example compounds physico-chemical data have been obtained and are displayed in order to illustrate the working of the present invention, including the outlined methods of synthesis. The number of given data may not be interpreted as a limitation of the invention.

TABLE B Comp. Melting point [° C.] or Comp. Melting point [° C.] or No. ¹H-NMR δ in ppm] No. ¹H-NMR δ in ppm]  1.001 162–163  1.301 215–218  1.002 178–179  1.210 154–155  1.003 154–155  1.079 165–166  1.004 134–135  3.002 175–176  1.005 167–168  6.002 89–90  1.006 154–155  7.002 oil**  1.015 213–214  1.254 >200  1.016 171–172  1.260 176–177  1.017 156–157 13.002 133–135  1.023 202–203 12.002 183–184  1.024 125–126  1.080 162–164  1.276 173–174  1.284 204–207  1.275 209–211  1.002* 177 (S-isomer; [α]_(D) = +70.80)  1.002* 177–178 (R-isomer; [α]_(D) = −72.0°)  1.222 ¹H-NMR (DMSO): 9.95 (s, 1 H); 8.57 (d, 1H); 8.53 (d, 1H); 8.36 (S, 1H); 7.89 (s, 1H); 7.80 (d, 1H); 7.65 (d, 1H); 7.42 (d, 1H); 7.19 (t, 1H); 6.88 (d, 1H); 4.57 (m, 1H); 4.15 (q, 2H); 3.80 (dq, 2H); 1.03 (d, 3H). 14.002 ¹H-NMR (CDCL3): 8.75 (s, 1H); 8.44 (m, 2H); 7.62 (d, 1H); 7.40–7.20 (m, 4H); 7.12 (d, 1H); 4.97 (m, 1H); 4.57 (t, 1H); 4.13 (m, 3H); 1.50 (d, 3H); 1.30 (t, 3H). 15.002 ¹H-NMR (CDCL3): 8.74 (s, 1H); 8.51 (d, 1H); 8.44 (d, 1H); 7.67 (d, 1H); 7.50 (s, 1H); 7.43–7.20 (m, 4H); 4.97 (m, 1H); 4.84 (d, 2H); 4.58 (t, 1H); 4.10 (m, 1H); 2.27 (t, 1H); 1.50 (d, 3H).  9.002 ¹H-NMR (CDCL₃): 8.78 (s, 1H); 8.70 (s, 1H); 8.45 (d, 1H); 7.62 (m, 2H); 7.40–7.20 (m, 4H); 5.00 (m, 1H); 4.58 (t, 1H); 4.32 (q, 2H); 4.12 (dd, 1H); 1.50 (d, 3H); 1.28 (t, 3H). 10.002 ¹H-NMR (DMSO): 8.88 (d, 1H); 8.81 (s, 1H); 8.60 (d, 1H); 7.98 (d, 1H); 7.82 (d, 1H); 7.50–7.18 (m, 4H); 4.90 (m, 1H); 4.58 (t, 1H); 4.13 (dd, 1H); 3.32 (s, 3H); 1.40 (d, 3H). 16.002 ¹H-NMR (DMSO): 8.74 (s, 1H); 8.59 (d, 1H); 8.54 (d, 1H); 7.74 (d, 1H); 7.51–7.30 (m, 5H); 5.51 (s, 2H); 4.88 (m, 1H); 4.56 (t, 1H); 4.12 (dd, 1H); 3.31 (s, 3H); 1.38 (d, 3H). 17002 ¹H-NMR (DMSO): 8.76 (s, 1H); 8.61 (d, 1H); 8.54 (d, 1H); 7.72 (d, 1H); 7.53–7.20 (M, 10H); 5.62 (s, 2H); 4.89 (m, 1H); 4.70 (s, 2H); 4.57 (m, 2H); 4.13 (dd, 1H); 1.40 (d, 3H). 18.002 ¹H-NMR (DMSO): 8.75 (s, 1H); 8.61 (d, 1H); 8.55 (d, 1H); 7.76 (d, 1H); 7.55–7.35 (m, 5H); 5.53 (s, 2H); 4.90 (m, 1H); 4.57 (t, 1H); 4.13 (dd, 1H); 3.74 (dd, 2H); 3.46 (dd, 2H); 3.22 (s, 3H); 1.39 (d, 3H). 19.002 ¹H-NMR (DMSO): 8.75 (s, 1H); 8.61 (d, 1H); 8.54 (d, 1H); 7.76 (d, 1H); 7.54–7.33 (m, 5H); 5.57 (s, 2H); 4.89 (m, 1H); 4.57 (t, 1H); 4.16 (dd, 1H); 3.91 (t, 2H); 3.75 (t, 2H); 1.39 (d, 3H). 20.002 ¹H-NMR (DMSO): 8.73 (s, 1H); 8.58 (d, 1H); 8.55 (d, 1H); 7.76 (d, 1H); 7.56–7.35 (m, 5H); 5.36 (s, 2H); 4.90 (m, 1H); 4.58 (t, 1H); 4.13 (dd, 1H); 2.12 (s, 3H); 1.40 (d, 3H). *pure enantiomer **NMR cf. experimental part, example 5

In the following, examples of test systems in plant protection are provided which can demonstrate the efficiency of the compounds of the formula I (designated as “active ingredient” or “test compounds”):

BIOLOGICAL EXAMPLES Example B-1 Effect against Puccinia graminis on wheat (brownrust on wheat)

a) Residual Protective Activity

1 week old wheat plants cv. Arina are treated with the formulated test-compound (0.02% active substance) in a spray chamber. Two days after application wheat plants are inoculated by spraying a spore suspension (1×10⁵ ureidospores/ml) on the test plants. After an incubation period of 1 day at +20° C. and 95% relative atmospheric humidity (r. h.) plants are kept for 9 days at +20° C. and 60% r.h. in a greenhouse. The disease incidence is assessed 10 days after inoculation.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002, 1.002*, 1.024, 1.080 and 7.002 exhibited over 70% control of the fungal infection in this test.

b) Systemic Activity

An aqueous spray liquor prepared from the formulated test compound (0.002% active substance, based on the volume of soil) is poured into pots with 5 days old wheat seedlings. Care is taken that the spray liquor does not come into contact with the above-ground parts of the plant. 4 days later, the plants are inoculated with a spore suspension of the fungus (1×10⁵ ureidospores/ml). After an incubation period of 1 day (95 to 100% r.h. at +20° C.), the plants are placed in a greenhouse at +20° C. 10 days after infection, the disease incidence is evaluated.

Compounds of Tables 1 to 20 show good activity in this test.

Example B-2 Effect against Phytophthora infestans on tomatoes (late blight on potato)

a) Residual Protective Activity

3 week old tomato plants cv. Roter Gnom are treated with the formulated test compound (0.02% active substance) in a spray chamber. Two day after application the plants are inoculated by spraying a sporangia suspension (2×10⁴ sporangia/ml) on the test plants. After an incubation period of 4 days at +18° C. and 95% r. h. in a growth chamber the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002*, 1.079 and 7.002 exhibited over 70% control of the fungal infection in this test.

b) Systemic Activity

An aqueous suspension prepared from the formulated test compound (0.002% active substance, based on the volume of soil) is poured into pots with 3 week old. Care is taken that the spray liquor does not come into contact with the above-ground parts of the plant. 4 days later, the plants are inoculated with a sporangia suspension of the fungus (2×10⁴ sporangia/ml). After an incubation period of 4 days at +18° C. and 95% r.h. in a growth chamber the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002*, 1.079 and 7.002 exhibited over 70% control of the fungal infection in this test.

Example B-3 Effect against Phytophthora infestans/potato (late blight on potato)

5 week old potato plants cv. Bintje are treated with the formulated test compound (0.02% active substance) in a spray chamber. Two days after application the plants are inoculated by spraying a sporangia suspension (1.4×10⁵ sporangia/ml) on the test plants. After an incubation period of 4 days at +18° C. and 95% r. h. in a growth chamber the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

Example B-4 Effect against Plasmopara viticola on grapevine (grape downy mildew)

5 week old grape seedlings cv. Gutedel are treated with the formulated test compound (0.02% active substance) in a spray chamber. One day after application grape plants are inoculated by spraying a sporangia suspension (4×10⁴ sporangia/ml) on the lower leaf side of the test plants. After an incubation period of 6 days at +22° C. and 95% r.h. in a greenhouse the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

Example B-5 Residual protective activity against Venturia inaegualis on apples (scab on apple)

4 week old apple seedlings cv. McIntosh are treated with the formulated test compound (0.02% active substance) in a spray chamber. One day after application apple plants are inoculated by spraying a spore suspension (4×10⁵ conidia/ml) on the test plants. After an incubation period of 4 days at +20° C. and 95% r. h. the plants are transferred to standard greenhouse conditions at 20 and 60% r.h. where they stayed for 2 days. After another 4 day incubation period at +20° C. and 95% r. h. the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002, 7.002 and 6.002 exhibited over 70% control of the fungal infection in this test.

Example B-6 Effect against Erysiphe graminis on barley (powdery mildew on barley)

a) Residual Protective Activity

Barley plants, cv. Regina of approximately 8 cm height were treated with the formulated test compound (0.02% active substance) in a spray chamber and duste 2 days after inoculation with conidia of the fungus. The infected plants are placed in a greenhouse at +20° C. 6 days after infection, the fungal attack was evaluated.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002, 1.003, 1.024, 14.002, 15.002 and 7.002 exhibited over 70% control of the fungal infection in this test.

b) Systemic Activity

An aqueous spray liquor prepared from the formulated test compound (0.002% active substance, based on the volume of soil) is poured into pots with 5 day old barley seedlings. Care is taken that the spray liquor does not come into contact with the above-ground parts of the plant. 4 days later, the plants are dusted with conidia of the fungus. The infected plants are placed in a greenhouse at +20° C. 6 days after infection, the disease incidence is evaluated.

Compounds of Tables 1 to 20 show good activity in this test.

Example B-7 Botrytis cinerea/grape (botrytis on grapes)

5 week old grape seedlings cv. Gutedel are treated with the formulated test compound (0.02% active substance) in a spray chamber. Two days after application grape plants are inoculated by spraying a spore suspension (1.5×10⁵ conidia/ml) on the test plants. After an incubation period of 3 days at +20° C. and 95% r. h. in a greenhouse the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002, 1.002*, 1.003, 1.024 and 7.002 exhibited over 70% control of the fungal infection in this test.

Example B-8 Effect against Botrytis cinerea/tomato (botrytis on tomatoes)

4 week old tomato plants cv. Roter Gnom are treated with the formulated test compound 0.02% active substance) in a spray chamber. Two days after application tomato plants are inoculated by spraying a spore suspension (1×1 05 conidia/ml) on the test plants. After an incubation period of 4 days at +20° C. and 95% r. h. in a greenhouse the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002, 1.002*, 1.017, 1.024 and 7.002 exhibited over 70% control of the fungal infection in this test.

Example B-9 Effect against Pyricularia orvzae/rice (rice blast)

3 week old rice plants cv. Sasanishiki are treated with the formulated test compound (0.02% active substance) in a spray chamber. Two days after application rice plants are inoculated by spraying a spore suspension (1×10⁵ conidia/ml) on the test plants. After an incubation period of 6 days at +25° C. and 95% r. h. the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.024 and 7.002 exhibited over 70% control of the fungal infection in this test.

Example B-10 Effect against Pyrenophora teres (Helminthosporium)/barley (net blotch on barley)

1 week old barley plants cv. Regina are treated with a formulated test compound (0.02% active substance) in a spray chamber. Two days after application barley plants are inoculated by spraying a spore suspension (3×10⁴ conidia/ml) on the test plants. After an incubation period of 2 days at +20° C. and 95% r.h. the disease incidence is assessed.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.001, 1.002, 1.002*, 1.003, 1.004, 1.017, 1.023, 1.024, 1.079, 1.275, 3.002, 6.002 and 7.002 exhibited over 70% control of the fungal infection in this test.

Example B-11 Effect against Fusarium culmorum/wheat (fusarium head blight on wheat)

A conidia suspension of F. culmorum (7×10⁵ conidia/ml) is mixed with the formulated test compound (0.002% active substance). The mixture is applied into a pouch which has been equipped before with a filter paper. After the application wheat seeds (cv. Orestis) are sown into the upper fault of the filter paper. The prepared pouches are then incubated for 11 days at approx. +10° C. to +18° C. and a relative humidity of 100% with a light period of 14 hours. The evaluation is made by assessing the degree of disease occurrence in the form of brown lesions on the roots.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002, 1.004, 1.005 and 7.002 exhibited over 70% control of the fungal infection in this test.

Example B-12 Effect Against Septoria nodorum/wheat (septoria leaf spot on wheat)

1 week old wheat plants cv. Arina are treated with a formulated test compound (0.02% active substance) in a spray chamber. One day after application wheat plants are inoculated by spraying a spore suspension (6×10⁵ conidia/ml) on the test plants. After an incubation period of 1 day at +22° C. and 95% r.h. plants are kept for 7 days at +22° C. and 60% r.h. in a greenhouse. The disease incidence is assessed 8 days after inoculation.

Compounds of Tables 1 to 20 show good activity in this test.

At the indicated concentration compounds 1.002, 1.002*, 1.003, 1.004, 1.017, 1.024, 1.079, 1.080, 1.260, 1.275, 3.002, 6.002, 10.002, 9.002, 14.002, 15.002, and 7.002 exhibited over 70% control of the fungal infection in this test. 

1. A compound of formula I

wherein the sum of (m+p) together is 0, 1, 2 or 3; n and q are independently of each other 0 or 1, and the sum of (m+p+q) together is 1, 2, 3 or 4; R₁ is hydrogen, halogen, alkoxy, haloalkyl, haloalkoxy or alkyl; R₂ is hydrogen, C₁–C₆-alkyl, C₁–C₆-haloalkyl or C₁–C₆-alkoxy; R_(2A) is hydrogen, C₁–C₆-alkyl, C₃–C₄-alkenyl or C₃–C₄-alkynyl; each of R₃, R₄, R₅ and R₆ is, independently of the others, hydrogen, C₁–C₆-alkyl, C₁–C₆-haloalkyl, hydroxy-C₁–C₆-alkyl or C₁–C₆-alkoxy-C₁–C₆-alkyl, or the ring members CR₃R₄ or CR₅R₆ or CR₂R_(2A) are independently of each other a carbonyl group (C═O) or a group C═S; X is C═O, C═S, S═O or O═S═O; Y is O, S, C═O, CH₂, —N(R₈)—, —O—N(R₈)—, —N(R₈)—O— or —NH—; R₇ is hydrogen, C₁–C₄-alkyl, C₃–C₄-alkenyl, C₃–C₄-alkynyl, —CH₂OR₈, CH₂SR₈, —C(O)R₈, —C(O)OR₈, SO2R₈, SOR₈ or SR₈; and R₈ is C₁–C₈-alkyl, C₁–C₈-alkoxyalkyl, C₁–C₈ haloalkyl or phenylC₁–C₂-alkyl wherein the phenyl may be substituted by up to three groups selected from halo or C₁–C₄-alkyl; or a salt thereof.
 2. A compound according to claim 1, wherein the moiety

represents a ring system selected from N-oxazolidin-2-one, N-oxazolidin-2-thione, N-[1,2,3]oxathiazolidine-2-oxide, N-[1,2,3]oxathiazolidine-2,2-dioxide, N-pyrrolidin-2-one, N-pyrrolidin-2-thione, N-pyrrolidine-2,5-dione, N-thiazolidin-2-one, N-4-methylene-oxazolidin-2-one, N-piperidine-2,6-dione, N-morpholine-2,3-dione, N-morpholine-2,5-dione, N-imidazolidin-2-one, N-[1,2,4]-oxazolidin-5-one, N-[1,2,4]-oxazolidin-3-one, N-[1,2,5]oxadiazinan-6-one, N-[1,2,4]oxadiazinan-3-one, azepan-2-one or [1,3]oxazinan-2-one.
 3. A compound according to claim 1, wherein R₁ is chlorine, fluorine, trifluoromethyl, trifluoromethoxy, or 1,1,2,2-tetrafluoroethoxy.
 4. A compound according to claim 1, wherein R₂ is hydrogen, methyl, trifluoromethyl or ethyl and R_(2A) is hydrogen or methyl.
 5. A compound according to claim 1, wherein R₇ is hydrogen, methyl, ethyl, allyl, propargyl, methoxymethyl, thiomethoxymethyl or ethoxymethyl.
 6. A compound according to claim 1, wherein X is carbonyl, C═S, or S═O and Y is oxygen and R₃, R₄, R₅ and R₆ are independently hydrogen or methyl.
 7. A compound according to claim 1, wherein R₁ is chlorine, fluorine, trifluoromethyl, trifluoromethoxy, or 1,1,2,2-tetrafluoroethoxy; R₂ is hydrogen, methyl, trifluoromethyl or ethyl; R_(2A) is hydrogen or methyl; R₅ and R₆ independently of each other are hydrogen, methyl, hydroxymethyl, hydroxyethyl, or methoxyethyl; R₇ is hydrogen, methyl, ethyl, allyl, propargyl, or methoxymethyl; X is carbonyl, C═S, or S═O; Y is oxygen, sulfur, —O—N(CH₃)—, or —N(CH₃)—O—; m and n are zero and p and q are each one.
 8. A compound according to claim 1, wherein R₁ is chlorine; R₂ is methyl or trifluoromethyl; R_(2A) is hydrogen or methyl; one of R₅ and R₆ is hydrogen or methyl, while the other one is hydrogen, methyl, hydroxymethyl, hydroxyethyl, or methoxyethyl; R₇ is hydrogen or methoxymethyl; X is carbonyl; Y is oxygen; m and n are zero and p and q are each one.
 9. A compound according to claim 1, wherein R₁ is chlorine; R₂ is methyl; R_(2A) is hydrogen; R₅ and R₆ independently of each other are hydrogen or methyl; R₇ is hydrogen or methoxymethyl; X is carbonyl; Y is oxygen; m and n are zero and p and q are each one.
 10. A compound according to claim 1, selected from the group comprising of 3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-oxazolidin-2-one, N-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-pyrrolidin-2-one, (3-chloro-phenyl)-{4-[2-(2-oxo-[1,2,3]oxathiazolidin-3-yl)-pyridin-4-yl]-pyrimidin-2-yl}-amine, 3-{4-[2-(3-fluoro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, 3-{4-[2-(3-trifluoromethyl-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, (3-chloro-phenyl)-{4-[2-(4-methyl-2-oxo-[1,2,3]oxathiazolidin-3-yl)-pyridin-4-yl]-pyrimidin-2-yl}-amine, 1-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-5-methyl-pyrrolidin-2-one, 3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-ethyl-oxazolidin-2-one, 3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-n-propyl-oxazolidin-2-one, 3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-i-propyl-oxazolidin-2-one, 3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-5-methyl-oxazolidin-2-one, 3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, 3-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidine-2-thione, (S)-3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, 3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-trifluoromethyl-oxazolidin-2-one, (R)-3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-oxazolidin-2-one, 3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-trifluoromethyl-[1,3]oxazinan-2-one 3-{4-[2-(3-Chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-4-methyl-[1,3]oxazinan-2-one, 1-{4-[2-(3-chloro-phenylamino)-pyrimidin-4-yl]-pyridin-2-yl}-5-trifluoromethyl-pyrrolidin-2-one, and 3-(4-{2-[(3-chloro-phenyl)-methoxymethyl-amino]-pyrimidin-4-yl}-pyridin-2-yl)-4-methyl-oxazolidin-2-one.
 11. A process for the preparation of the compound according to claim 1, comprising a) reacting a compound of the formula (II)

(or a salt thereof) wherein U is a leaving group, and the other moieties have the meanings given for a compound of the formula I, with a cyclic amine ring system of the formula III

(or a salt thereof) wherein R₂ to R₆, R_(2A), X, Y, m, p and q have the meanings given for a compound of the formula I, in presence of a palladium catalyst or in the presence of a base, or b) cyclizing a compound of the formula IV

wherein R₁ to R₇, R_(2A), X, Y, n, m, p and q have the meanings given for a compound of the formula I and U′ is a leaving group, by heating it optionally in presence of a base, or c) reacting a compound of the formula V

wherein q is 1 and R₁, R₂, R_(2A), R₅, R₆, R₇, Y, n and p have the meanings given for a compound of the formula I, with phosgene, di- or triphosgene, carbonyldiimidazol, thiophosgene, thiocarbonyldiimidazol or thionylchloride thus obtaining a compound of the subformula Ia

wherein X is C═O, C═S or S═O, q is 1 and R₁, R₂, R_(2A), R₅, R₆, R₇, Y, n and p have the meanings given for a compound of the formula I, or d) oxidizing of a compound of the subformula Ib

wherein R₁ to R₇, R_(2A), Y, n, m, p and q have the meanings given for a compound of the formula I with an oxidizing amount of NaIO₄/RuCl₃, NaOCl/RuO₂ or KMnO₄, in order to form a compound of the formula I, wherein X is O═S═O, or e) reacting a compound of the formula VI

wherein R₁ to R₇, R_(2A), Y, n, m, p and q have the meanings given for a compound of the formula I with an oxidizing amount of iodine, in order to form a compound of the formula I, wherein X is S═O.
 12. A composition for controlling and protecting against phytopathogenic microorganisms, comprising a compound of formula I according to claim 1 as active ingredient together with a suitable carrier.
 13. A method of controlling and preventing an infestation of crop plants by phytopathogenic microorganisms, which comprises the application of a compound of formula I according to claim 1 as active ingredient to the plant, to parts of plants or to the locus thereof.
 14. A method according to claim 13, wherein the phytopathogenic microorganisms are fungal organisms. 